378 related articles for article (PubMed ID: 30927978)
21. "Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remission.
Rady K; Blombery P; Westerman DA; Wall M; Curtis M; Campbell LJ; Seymour JF
Leuk Res; 2018 Oct; 73():1-4. PubMed ID: 30170269
[TBL] [Abstract][Full Text] [Related]
22. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q).
Kanagal-Shamanna R; Yin CC; Miranda RN; Bueso-Ramos CE; Wang XI; Muddasani R; Medeiros LJ; Lu G
Cancer Genet; 2013; 206(1-2):42-6. PubMed ID: 23357231
[TBL] [Abstract][Full Text] [Related]
23. Epidemiologic outlook of therapy-related myeloid neoplasms and selection of high-risk patients: A Korean nationwide study.
Ha H; Kim HJ; Park JH; Shin A; Lee KN; Han K; Lee NR; Hong J
Cancer; 2022 Nov; 128(21):3888-3896. PubMed ID: 36069361
[TBL] [Abstract][Full Text] [Related]
24. Therapy-related myelodysplastic syndrome following cyclophosphamide pulse and/or methotrexate therapy in a patient with systemic lupus erythematosus.
Iwadate H; Kobayashi H; Yano K; Watanabe H; Ikeda K; Ogawa K; Ohira H
Fukushima J Med Sci; 2010 Dec; 56(2):121-7. PubMed ID: 21502712
[TBL] [Abstract][Full Text] [Related]
25. Acute myelogenous leukemia following immunosuppressive therapy for rheumatoid arthritis.
Kapadia SB; Kaplan SS
Am J Clin Pathol; 1978 Aug; 70(2):301-2. PubMed ID: 279231
[TBL] [Abstract][Full Text] [Related]
26. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
27. Secondary acute myeloid leukemia arising early after cyclophosphamide treatment.
Koklu H; Tufan A; Erkul Y; Akyurek N; Civelek R
Int J Clin Pharm; 2015 Apr; 37(2):289-91. PubMed ID: 25612567
[TBL] [Abstract][Full Text] [Related]
28. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
29. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
30. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
31. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
32. [Detecting shared pathways linked to rheumatoid arthritis with other autoimmune diseases in a in silico analysis].
Zheng WY; Zheng WX; Hua L
Mol Biol (Mosk); 2016; 50(3):530-9. PubMed ID: 27414792
[TBL] [Abstract][Full Text] [Related]
33. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
34. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
35. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
[TBL] [Abstract][Full Text] [Related]
36. [Impacts of new agents for multiple myeloma on development of secondary myelodysplastic syndrome and acute myeloid leukemia].
Hamano A; Shingaki S; Abe Y; Miyazaki K; Sekine R; Nakagawa Y; Tsukada N; Hattori Y; Suzuki K
Rinsho Ketsueki; 2014 Apr; 55(4):428-35. PubMed ID: 24850453
[TBL] [Abstract][Full Text] [Related]
37. Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?
Madanat YF; Gerds AT
Best Pract Res Clin Haematol; 2019 Mar; 32(1):104-113. PubMed ID: 30927969
[TBL] [Abstract][Full Text] [Related]
38. Myeloid leukaemia in systemic lupus erythematosus--a nested case-control study based on Swedish registers.
Löfström B; Backlin C; Sundström C; Hellström-Lindberg E; Ekbom A; Lundberg IE
Rheumatology (Oxford); 2009 Oct; 48(10):1222-6. PubMed ID: 19608725
[TBL] [Abstract][Full Text] [Related]
39. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.
Kim YG; Cho SY; Park TS; Oh SH; Yoon HJ
Ann Clin Lab Sci; 2011; 41(1):79-83. PubMed ID: 21325260
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia and other myelopathic disorders following treatment with alkylating agents.
Bennett JM; Moloney WC; Greene MH; Boice JD
Hematol Pathol; 1987; 1(2):99-104. PubMed ID: 3504435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
